The study is a prospective, randomized, open-label study.
The principal objective of this trial is to investigate the effect of a comprehensive behavioural treatment program on weight gain in schizophrenic patients under olanzapine treatment, and on subjective well-being.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
100
12 sessions, psychoeducation
2 weekly, 12 sessions, psychoeducational weight management
Heinrich-Heine-University, Rhineland State Clinics Düsseldorf
Düsseldorf, Rhineland State, Germany
difference in mean weight gain
Time frame: November 2007
changes in waist circumference, blood pressure, blood lipids, fasting glucose
Time frame: November 2007
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.